Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies
Tuesday, the FDA said it received reports of patients developing T-cell malig
Analyst Bullish On Boeing: 2024 Outlook Promises Recovery Amid Supply Chain Woes
RBC Capital Markets upgraded Boeing Company (NYSE: BA), noting the early stages of a significant shift in
Merck Highlights Data On New Vaccine, Compares ‘Tolerability And Safety’ To Pfizer’s
Merck & Co Inc (NYSE: MRK) released results from the STRIDE-3 Phase 3 trial evaluating V116, the company's investigational 21-valent
Novartis Outlines Pure-Play Strategy Progress After Generics Business Spin-Off
Novartis AG (NYSE: NVS) has outlined the progress made in delivering its pure-play strategy, focused on four core therapeutic areas (Cardiovascular-Renal-Metabolic, Immunology, Neuroscience, Oncology), two plus three technology platforms (Chemistry, Biotherapeutics, xRNA, Radioligand, Gene & Cell Therapy) in four priority geographies (US, China, Germany, Japan).
Why Is RNA Therapeutics-Focused Avidity Biosciences Stock Trading Higher Today?
Avidity Biosciences Inc (NASDAQ: RNA) announced a global licensing and research collaboration with Bristol Myers Squibb & Co (NYSE: BMY) focused on discovering, developing, and commercializing multiple ca
S&P 500’s 2024 Target Of 5,000: Bank of America’s Optimistic Forecast Diversifies Beyond Magnificent 7
Bank of America forecasts S&P 500 to reach 5,000 points by 2024, a 10% leap from current standings. Cyclicals and automation to drive growth, while tech faces regulatory scrutiny, crowding and valuation risks.
Eli Lilly’s Blockbuster Mounjaro Shows Larger, Faster Weight Loss Than Novo Nordisk’s Ozempic In Real World Study
A recent extensive analysis by Truveta Research has
VIX At Pre-Pandemic Low: Is Wall Street’s Fear Gauge Mispricing Risk Of Downturn?
VIX index hits lowest point since pandemic, as equities try to regain 2023 highs; it's seen as a measure of market volatility, higher means more uncertainty, lower usually good for stocks.
Tesla’s Nordic Nightmare: A Swedish Union Showdown Threatens Musk’s Anti-Union Fortress In America
Tesla Inc's conflict with car mechanics in Sweden has escalated, with lawsuit vs Swedish state, solidarity strikes, & roadblocks from trade unions.
Oil Majors: Are BP And Chevron Attractively Valued After Share Price Tumbles?
BP shares have fallen sharply since February, but with an attractive dividend yield, could now be time to buy?